Belpomme D - Search Results

1

Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate.

Calabresse C, Venturini L, Ronco G, Villa P, Degos L, Belpomme D, Chomienne C. Calabresse C, et al. Among authors: belpomme d. Biochem Biophys Res Commun. 1994 May 30;201(1):266-83. doi: 10.1006/bbrc.1994.1698. Biochem Biophys Res Commun. 1994. PMID: 8198584

2

Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line.

Calabresse C, Venturini L, Ronco G, Villa P, Chomienne C, Belpomme D. Calabresse C, et al. Among authors: belpomme d. Biochem Biophys Res Commun. 1993 Aug 31;195(1):31-8. doi: 10.1006/bbrc.1993.2005. Biochem Biophys Res Commun. 1993. PMID: 8363611

3

Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study.

Belpomme D, Krakowski I, Beauduin M, Petit T, Canon JL, Janssens J, Gauthier S, De Pauw A, Moreau V, Kayitalire L. Belpomme D, et al. Gynecol Oncol. 2003 Oct;91(1):32-8. doi: 10.1016/s0090-8258(03)00413-x. Gynecol Oncol. 2003. PMID: 14529659 Clinical Trial.

4

[Response of bone metastases to medical treatment: definition of evaluation criteria and classification trials].

Belpomme D, Droz JP, Marie FN, Namer M, Tan TN, Pecking A, Rouesse J, Vanel D, Bock P, Cappelaere P, et al. Belpomme D, et al. Bull Cancer. 1989;76(3):273-89. Bull Cancer. 1989. PMID: 2736314 French.

5

Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma.

Belpomme D, Gauthier S, Pujade-Lauraine E, Facchini T, Goudier MJ, Krakowski I, Netter-Pinon G, Frenay M, Gousset C, Marié FN, Benmiloud M, Sturtz F. Belpomme D, et al. Ann Oncol. 2000 Nov;11(11):1471-6. doi: 10.1023/a:1026556119020. Ann Oncol. 2000. PMID: 11142488 Free article. Clinical Trial.

6

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.

Kemp G, Rose P, Lurain J, Berman M, Manetta A, Roullet B, Homesley H, Belpomme D, Glick J. Kemp G, et al. Among authors: belpomme d. J Clin Oncol. 1996 Jul;14(7):2101-12. doi: 10.1200/JCO.1996.14.7.2101. J Clin Oncol. 1996. PMID: 8683243 Clinical Trial.

7

Advanced ovarian cancer. Carboplatin versus cisplatin.

Vermorken JB, ten Bokkel Huinink WW, Eisenhauer EA, Favalli G, Belpomme D, Conte PF, Kaye SB. Vermorken JB, et al. Among authors: belpomme d. Ann Oncol. 1993;4 Suppl 4:41-8. Ann Oncol. 1993. PMID: 8312200 Review.

8

Advanced epithelial ovarian cancer: 1993 consensus statements.

Allen DG, Baak J, Belpomme D, Berek JS, Bertelsen K, ten Bokkel Huinink WW, van der Burg ME, Calvert AH, Conte PF, Dauplat J, et al. Allen DG, et al. Among authors: belpomme d. Ann Oncol. 1993;4 Suppl 4:83-8. doi: 10.1093/annonc/4.suppl_4.s83. Ann Oncol. 1993. PMID: 8312205 Review.

9

[Life span of human leukemic blood cell cultures].

Belpomme D, Blondel P, Grandjon D. Belpomme D, et al. C R Acad Hebd Seances Acad Sci D. 1972 Jun 19;274(25):3480-3. C R Acad Hebd Seances Acad Sci D. 1972. PMID: 4626117 French. No abstract available.

10

Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer.

Pivot X, Wadler S, Kelly C, Ruxer R, Tortochaux J, Stern J, Belpomme D, Humblet Y, Domenge C, Clendeninn N, Johnston A, Penning C, Schneider M. Pivot X, et al. Among authors: belpomme d. Ann Oncol. 2001 Nov;12(11):1595-9. doi: 10.1023/a:1013185402896. Ann Oncol. 2001. PMID: 11822760 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters